HUP0401776A2 - Intraorally disintegrating valdecoxid compositions prepared by spray drying process - Google Patents
Intraorally disintegrating valdecoxid compositions prepared by spray drying processInfo
- Publication number
- HUP0401776A2 HUP0401776A2 HU0401776A HUP0401776A HUP0401776A2 HU P0401776 A2 HUP0401776 A2 HU P0401776A2 HU 0401776 A HU0401776 A HU 0401776A HU P0401776 A HUP0401776 A HU P0401776A HU P0401776 A2 HUP0401776 A2 HU P0401776A2
- Authority
- HU
- Hungary
- Prior art keywords
- valdecoxid
- drying process
- spray drying
- compositions prepared
- intraorally disintegrating
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 238000001694 spray drying Methods 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 102000010907 Cyclooxygenase 2 Human genes 0.000 abstract 1
- 108010037462 Cyclooxygenase 2 Proteins 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 230000001404 mediated effect Effects 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- LNPDTQAFDNKSHK-UHFFFAOYSA-N valdecoxib Chemical compound CC=1ON=C(C=2C=CC=CC=2)C=1C1=CC=C(S(N)(=O)=O)C=C1 LNPDTQAFDNKSHK-UHFFFAOYSA-N 0.000 abstract 1
- 229960002004 valdecoxib Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Heart & Thoracic Surgery (AREA)
- Pregnancy & Childbirth (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Zoology (AREA)
Abstract
A találmány orálisan széteső, gyorsan szétmálló valdekoxib tablettákraés ilyen dózisformák előállítására alkalmas eljárásra vonatkozik. Akészítmények ciklooxigenáz-2 által közvetített betegségállapotok ésrendellenességek kezelésére vagy megelőzésére használhatók. ÓThe invention relates to orally disintegrating, rapidly disintegrating valdecoxib tablets and a suitable method for producing such dosage forms. The preparations can be used to treat or prevent disease states and disorders mediated by cyclooxygenase-2. HE
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32808801P | 2001-10-10 | 2001-10-10 | |
| PCT/US2002/032333 WO2003030876A1 (en) | 2001-10-10 | 2002-10-10 | Intraorally disintegrating valdecoxib compositions prepared by spray drying process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUP0401776A2 true HUP0401776A2 (en) | 2004-12-28 |
Family
ID=23279455
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0401776A HUP0401776A2 (en) | 2001-10-10 | 2002-10-10 | Intraorally disintegrating valdecoxid compositions prepared by spray drying process |
Country Status (28)
| Country | Link |
|---|---|
| EP (1) | EP1450769A1 (en) |
| JP (1) | JP2005508348A (en) |
| KR (1) | KR20050035138A (en) |
| CN (1) | CN1602187A (en) |
| AP (1) | AP2004003022A0 (en) |
| BG (1) | BG108675A (en) |
| BR (1) | BR0213152A (en) |
| CA (1) | CA2462881A1 (en) |
| CO (1) | CO5570687A2 (en) |
| CZ (1) | CZ2004456A3 (en) |
| EA (1) | EA200400423A1 (en) |
| EC (1) | ECSP045056A (en) |
| GE (1) | GEP20063857B (en) |
| HR (1) | HRP20040331A2 (en) |
| HU (1) | HUP0401776A2 (en) |
| IL (1) | IL161253A0 (en) |
| IS (1) | IS7211A (en) |
| MA (1) | MA27543A1 (en) |
| MX (1) | MXPA04003404A (en) |
| NO (1) | NO20041894L (en) |
| NZ (1) | NZ532184A (en) |
| OA (1) | OA12666A (en) |
| PL (1) | PL370136A1 (en) |
| SK (1) | SK1662004A3 (en) |
| TN (1) | TNSN04056A1 (en) |
| WO (1) | WO2003030876A1 (en) |
| YU (1) | YU37104A (en) |
| ZA (1) | ZA200402728B (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7815937B2 (en) | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
| WO2012087113A1 (en) * | 2010-12-24 | 2012-06-28 | N.V. Nutricia | Improved nutritional tablet |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5576014A (en) * | 1994-01-31 | 1996-11-19 | Yamanouchi Pharmaceutical Co., Ltd | Intrabuccally dissolving compressed moldings and production process thereof |
| KR100373622B1 (en) * | 1996-05-17 | 2003-07-12 | 머크 앤드 캄파니 인코포레이티드 | One-time therapeutic composition for diseases mediated with cyclooxygenase-2 |
| KR100664479B1 (en) * | 1999-12-08 | 2007-01-04 | 파마시아 코포레이션 | Valdecoxib composition |
| US6316029B1 (en) * | 2000-05-18 | 2001-11-13 | Flak Pharma International, Ltd. | Rapidly disintegrating solid oral dosage form |
| US20020071857A1 (en) * | 2000-08-18 | 2002-06-13 | Kararli Tugrul T. | Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| CN1638739A (en) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | Compound for treating assuetude disturbance |
-
2002
- 2002-10-10 EA EA200400423A patent/EA200400423A1/en unknown
- 2002-10-10 GE GE5526A patent/GEP20063857B/en unknown
- 2002-10-10 JP JP2003533908A patent/JP2005508348A/en not_active Withdrawn
- 2002-10-10 IL IL16125302A patent/IL161253A0/en unknown
- 2002-10-10 NZ NZ532184A patent/NZ532184A/en unknown
- 2002-10-10 PL PL02370136A patent/PL370136A1/en not_active Application Discontinuation
- 2002-10-10 AP APAP/P/2004/003022A patent/AP2004003022A0/en unknown
- 2002-10-10 SK SK166-2004A patent/SK1662004A3/en unknown
- 2002-10-10 CZ CZ2004456A patent/CZ2004456A3/en unknown
- 2002-10-10 YU YU37104A patent/YU37104A/en unknown
- 2002-10-10 OA OA1200400101A patent/OA12666A/en unknown
- 2002-10-10 EP EP02784064A patent/EP1450769A1/en not_active Withdrawn
- 2002-10-10 CN CNA028246772A patent/CN1602187A/en active Pending
- 2002-10-10 WO PCT/US2002/032333 patent/WO2003030876A1/en not_active Application Discontinuation
- 2002-10-10 BR BR0213152-8A patent/BR0213152A/en not_active IP Right Cessation
- 2002-10-10 KR KR1020047005233A patent/KR20050035138A/en active IP Right Grant
- 2002-10-10 CA CA002462881A patent/CA2462881A1/en not_active Abandoned
- 2002-10-10 HU HU0401776A patent/HUP0401776A2/en unknown
- 2002-10-10 MX MXPA04003404A patent/MXPA04003404A/en unknown
-
2004
- 2004-04-07 IS IS7211A patent/IS7211A/en unknown
- 2004-04-07 CO CO04033066A patent/CO5570687A2/en not_active Application Discontinuation
- 2004-04-07 TN TNP2004000056A patent/TNSN04056A1/en unknown
- 2004-04-07 ZA ZA200402728A patent/ZA200402728B/en unknown
- 2004-04-08 HR HR20040331A patent/HRP20040331A2/en not_active Application Discontinuation
- 2004-04-08 EC EC2004005056A patent/ECSP045056A/en unknown
- 2004-04-08 MA MA27620A patent/MA27543A1/en unknown
- 2004-04-08 BG BG108675A patent/BG108675A/en unknown
- 2004-05-07 NO NO20041894A patent/NO20041894L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| IL161253A0 (en) | 2004-09-27 |
| CZ2004456A3 (en) | 2005-03-16 |
| CO5570687A2 (en) | 2005-10-31 |
| HRP20040331A2 (en) | 2005-12-31 |
| CA2462881A1 (en) | 2003-04-17 |
| NO20041894D0 (en) | 2004-05-07 |
| GEP20063857B (en) | 2006-06-26 |
| YU37104A (en) | 2006-08-17 |
| NZ532184A (en) | 2005-12-23 |
| WO2003030876A1 (en) | 2003-04-17 |
| CN1602187A (en) | 2005-03-30 |
| BR0213152A (en) | 2004-10-19 |
| PL370136A1 (en) | 2005-05-16 |
| AP2004003022A0 (en) | 2004-06-30 |
| BG108675A (en) | 2005-03-31 |
| EP1450769A1 (en) | 2004-09-01 |
| ECSP045056A (en) | 2004-08-27 |
| JP2005508348A (en) | 2005-03-31 |
| TNSN04056A1 (en) | 2006-06-01 |
| MXPA04003404A (en) | 2004-06-18 |
| MA27543A1 (en) | 2005-10-03 |
| IS7211A (en) | 2004-04-07 |
| OA12666A (en) | 2006-06-19 |
| KR20050035138A (en) | 2005-04-15 |
| SK1662004A3 (en) | 2005-07-01 |
| EA200400423A1 (en) | 2004-10-28 |
| ZA200402728B (en) | 2005-03-17 |
| NO20041894L (en) | 2004-07-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE453642T1 (en) | SUBSTITUTED PHENYLAMINOPYRIMIDINES | |
| WO2003026623A8 (en) | Intraorally disintegrating valdecoxib compositions | |
| WO2002100347A3 (en) | Prodrugs of gaba analogs, compositions and uses thereof | |
| NO20055863L (en) | W-carboxyaryl-substituted diphenylurea compounds as raf kinase inhibitors | |
| DE502005006149D1 (en) | HETARYLOXY-SUBSTITUTED PHENYLAMINOPYRIMIDINES AS RHO-KINASE HEMMER | |
| NO20064041L (en) | Substituted pyrazoline compositions, their preparation and use as drugs | |
| MX2007002470A (en) | Substituted phenylaminothiazoles and use thereof. | |
| PL372809A1 (en) | Substituted 1,3-diphenylprop-2-en-1-one derivatives and preparation and uses thereof | |
| WO2004078116A3 (en) | P38 inhibitors and methods of use thereof | |
| PL351125A1 (en) | Derivatives of 4,5-diaryl-3(2)-furanone as inhibitors of cykoxygenease-2 | |
| NO20034549L (en) | Treatment of type 2 diabetes with dipeptidyl peptidase IV inhibitors | |
| NO20060328L (en) | Combination of mGluR2 antagonist and ACHE inhibitor for the treatment of acute and / or chronic neurological disorders | |
| NO20056161L (en) | Formulations for the treatment of arthritis | |
| NO20052169L (en) | Dihydropyridine compounds with simultaneous ability to block L-type calcium channels and inhibit phosphodiesterase type 3 activity | |
| MY134480A (en) | 4-pyrrolidino-phenyl-benzyl ether derivatives | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| WO2003106450A8 (en) | Phenylaminopyrimidines and their use as rho-kinase inhibitors | |
| WO2003026610A3 (en) | Process for the preparation of fast dissolving dosage form | |
| ZA200308353B (en) | Compaction process for manufacture of sodium phenytoin dosage form. | |
| DE50105771D1 (en) | IBUPROFEN-ACTIVE PREPARATION | |
| TW200510308A (en) | Isophthalic acid derivatives | |
| NO20033318D0 (en) | 2H-1-benzopyran derivatives, process of manufacture, and pharmaceutical compositions thereof | |
| NO20054346L (en) | Compositions and methods for the prevention and treatment of endotoxin-related diseases and conditions | |
| EA200501865A1 (en) | ANALOGUES OF TIOVOLFRAMATOV AND THEIR APPLICATION | |
| HUP0401776A2 (en) | Intraorally disintegrating valdecoxid compositions prepared by spray drying process |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |